Ruhul H. Choudhury
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
SC134-deruxtecan, a fucosyl-GM1 targeting ADC for small cell lung cancer therapy.
Journal: Journal of translational medicine
Published: June 13, 2025
NOTUM-mediated WNT silencing drives extravillous trophoblast cell lineage development.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 26, 2024
SC134-TCB Targeting Fucosyl-GM1, a T Cell-Engaging Antibody with Potent Antitumor Activity in Preclinical Small Cell Lung Cancer Models.
Journal: Molecular cancer therapeutics
Published: March 15, 2024
NOTUM-MEDIATED WNT SILENCING DRIVES EXTRAVILLOUS TROPHOBLAST CELL LINEAGE DEVELOPMENT.
Journal: bioRxiv : the preprint server for biology
Published: February 26, 2024
Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy.
Journal: Frontiers in immunology
Published: October 10, 2022
Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool.
Journal: Immunology
Published: February 24, 2022
Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity.
Journal: Frontiers in immunology
Published: February 11, 2022
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: January 08, 2022
Intersection of regulatory pathways controlling hemostasis and hemochorial placentation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 29, 2021
Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 02, 2021
ASCL2 reciprocally controls key trophoblast lineage decisions during hemochorial placenta development.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 02, 2021
Last Updated: 09/26/2026